SMIH: Summit Healthcare Acquisition Corp. - Summary | Jitta

Summit Healthcare Acquisition Corp.

NASDAQ:SMIH

Notice
Stock data is unavailable or the company’s delisted.
Price
$9.10
Loss Chance
58.4%
n/aJITTA SCORE
534.02%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (12)
Recent Business Performance (25)
Financial Strength (8)
Return to Shareholders (0)
Competitive Advantage (1)
Jitta Signs
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 225.11% in the last quarter (yoy)
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
n/a
534.02%
2.08
348.05%
2.08
348.05%
4.41
53.66%
COMPANY DESCRIPTION
As of March 16, 2023, Summit Healthcare Acquisition Corp. was acquired by Yisheng Biopharma Co., Ltd., in a reverse merger transaction. Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.